Refine
Year of publication
- 2011 (328) (remove)
Institute
- Fachbereich Medizintechnik und Technomathematik (82)
- Fachbereich Elektrotechnik und Informationstechnik (40)
- INB - Institut für Nano- und Biotechnologien (37)
- Fachbereich Wirtschaftswissenschaften (34)
- IfB - Institut für Bioengineering (34)
- Fachbereich Energietechnik (29)
- Fachbereich Chemie und Biotechnologie (28)
- Fachbereich Bauingenieurwesen (24)
- Fachbereich Maschinenbau und Mechatronik (24)
- Fachbereich Luft- und Raumfahrttechnik (23)
Document Type
- Article (182)
- Conference Proceeding (76)
- Book (24)
- Part of a Book (21)
- Report (7)
- Patent (5)
- Conference: Meeting Abstract (3)
- Other (3)
- Doctoral Thesis (2)
- Part of a Periodical (2)
Keywords
- Aachen / Fachhochschule Aachen (3)
- Aachen University of Applied Sciences (3)
- Aktionskunst (3)
- FH Aachen (2)
- Illustration (2)
- Interaktive Kunst (2)
- Kommunikationsguerrilla (2)
- Pflanzenphysiologie (2)
- Pflanzenscanner (2)
- Stadtgestaltung (2)
The contribution of altered post-transcriptional gene silencing to the development of insulin resistance and type 2 diabetes mellitus so far remains elusive. Here, we demonstrate that expression of microRNA (miR)-143 and 145 is upregulated in the liver of genetic and dietary mouse models of obesity. Induced transgenic overexpression of miR-143, but not miR-145, impairs insulin-stimulated AKT activation and glucose homeostasis. Conversely, mice deficient for the miR-143–145 cluster are protected from the development of obesity-associated insulin resistance. Quantitative-mass-spectrometry-based analysis of hepatic protein expression in miR-143-overexpressing mice revealed miR-143-dependent downregulation of oxysterol-binding-protein-related protein (ORP) 8. Reduced ORP8 expression in cultured liver cells impairs the ability of insulin to induce AKT activation, revealing an ORP8-dependent mechanism of AKT regulation. Our experiments provide direct evidence that dysregulated post-transcriptional gene silencing contributes to the development of obesity-induced insulin resistance, and characterize the miR-143–ORP8 pathway as a potential target for the treatment of obesity-associated diabetes.